Clinical Trials Logo
  1. Home
  2. Other
  3. NCT02291393

The Role of High Density Surface ECG in the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Arrhythmogenic Right Ventricular Cardiomyopathy Clinical Trial

Official title:
The Role of High Density Surface Cardiac Electrographic Mapping in the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy :A Pilot Study

Clinical Trial Summary

The diagnosis of Arrhythmogenic right ventricular cardiomyopathy can be difficult. The 80 lead ECG may increase the specificity and sensitivity in diagnosing this potentially life threatening inherited cardiac condition. This pilot would form the basis of a much larger clinical trial to test the utility of this novel diagnostic tool.

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

  • Arrhythmogenic Right Ventricular Cardiomyopathy
  • Arrhythmogenic Right Ventricular Dysplasia
  • Cardiomyopathies
Clinical Trial Details
NCT number NCT02291393
Study type Interventional
Source The Leeds Teaching Hospitals NHS Trust
Contact
Status Completed
Phase N/A
Start date August 2012
Completion date October 2012
View Details
See also
  Status Clinical Trial Phase
Completed NCT03177018 - DNA Analysis From Isolated Cardiomyocytes in the Molecular Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia N/A
Recruiting NCT05799833 - Low QRS Voltages in Young Healthy Individuals and Athletes
Recruiting NCT03061994 - Metabolomic Study of All-age Cardiomyopathy N/A
Completed NCT00292032 - Registry of Unexplained Cardiac Arrest
Completed NCT04124237 - Long Term Monitoring for Risk of Sudden Death
Enrolling by invitation NCT03527342 - Sahlgrenska Cardiomyopathy Project
Completed NCT03685149 - Pilot Randomized Trial With Flecainide in ARVC Patients Phase 2
Recruiting NCT03076580 - An Integrative-"Omics" Study of Cardiomyopathy Patients for Diagnosis and Prognosis in China
Completed NCT02302274 - Diagnostic Value and Safety of Flecainide Infusion Test in Brugada Syndrome
Recruiting NCT06311708 - Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Recruiting NCT03572569 - Risk Stratification in Children and Adolescents With Primary Cardiomyopathy
Completed NCT01804699 - National ARVC Data Registry and Bio Bank
Recruiting NCT05024708 - Athlete's Heart or Arrhythmogenic Right Ventricular Cardiomyopathy: Contribution of Exercise Cardiovascular Magnetic Resonance (CMR) N/A
Recruiting NCT03049254 - Mayo AVC Registry and Biobank
Recruiting NCT02989480 - PET-detected Myocardial Inflammation is a Characteristic of Cardiac Sarcoid But Not of ARVC
Recruiting NCT04265040 - DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studies
Recruiting NCT06040242 - Arrhythmogenic Activity During Exercise in ARVC Patients N/A
Recruiting NCT02432092 - Pediatric Cardiomyopathy Mutation Analysis
Active, not recruiting NCT04895540 - South Asian Arrhythmogenic Cardiomyopathy Registry
Recruiting NCT06228924 - Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC Phase 1